Proposed acquisition by Baxter Healthcare Corporation of 20% of Acambis plc formerly known as Peptide Therapeutics Group plc

No. ME/1109/01

Cleared in accordance with the Director General of Fair Trading's advice.

Back to top

Advice and resources

  • OFT telephone enquiries:08457 22 44 99
  • Consumer Direct telephone enquiries:08454 04 05 06